The mega trade deal TPP, which includes the US and 11 other countries, is likely to have "serious implications" on the growth of domestic pharma industry, particularly the generic market, a study said.
According to the report 'Indian Pharmaceutical Industry: Challenges and Prospects', even as the domestic pharmaceutical industry has acquired a noteworthy position in the global markets, there are various challenges faced with regard to the changing regulatory environment and slowdown in trade.
(Reference: http://www.businesstoday.in/sectors/pharma/tpp-to-have-serious-implications-for-pharma-industry/story/236912.html)